MoneyWorks4Me

Smruthi Organics - Quaterly Results

14 May 2026 Evaluate
The sales slipped to Rs. 290.89 millions for the March 2026 quarter as against Rs. 380.94 millions during the year-ago period.The Net Profit of the company slipped to Rs. 10.65 millions from Rs. 22.30 millions, a decline of -52.24% on QoQ basis.Operating Profit reported a sharp decline to 38.12 millions from 47.55 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 290.89 380.94 -23.64 1019.67 1260.08 -19.08 1019.67 1260.08 -19.08
Other Income 0.17 0.76 -77.63 1.24 0.89 39.33 1.24 0.89 39.33
PBIDT 38.12 47.55 -19.83 131.59 122.71 7.24 131.59 122.71 7.24
Interest 3.11 5.16 -39.73 16.84 18.70 -9.95 16.84 18.70 -9.95
PBDT 34.90 42.39 -17.67 110.12 104.01 5.87 110.12 104.01 5.87
Depreciation 17.53 15.04 16.56 63.49 55.01 15.42 63.49 55.01 15.42
PBT 17.37 27.35 -36.49 46.63 49.00 -4.84 46.63 49.00 -4.84
TAX 6.72 5.05 33.07 12.39 13.37 -7.33 12.39 13.37 -7.33
Deferred Tax 0.52 0.19 173.68 -2.00 -0.32 525.00 -2.00 -0.32 525.00
PAT 10.65 22.30 -52.24 34.24 35.63 -3.90 34.24 35.63 -3.90
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 13.10 12.48 4.99 12.91 9.74 32.52 12.91 9.74 32.52
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..